Outcomes following bioprosthetic valve replacement in prior non‐cardiac transplant recipients

2019 ◽  
Vol 33 (11) ◽  
Author(s):  
Sabin J. Bozso ◽  
Jimmy J. H. Kang ◽  
David Al‐Adra ◽  
Yongzhe Hong ◽  
Michael C. Moon ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Bioprosthetic Valve ◽  
Cardiac Transplant ◽  
Transplant Recipients ◽  
Bioprosthetic Valve Replacement

scholarly journals Mechanical Valve Replacement Versus Bioprosthetic Valve Replacement in the Tricuspid Valve Position

2013 ◽  
Vol 28 (3) ◽  
pp. 212-217 ◽  
Author(s):  
Won-Chul Cho ◽  
Chong Bin Park ◽  
Joon Bum Kim ◽  
Sung-Ho Jung ◽  
Cheol Hyun Chung ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Tricuspid Valve ◽  
Mechanical Valve ◽  
Bioprosthetic Valve ◽  
Valve Position ◽  
Bioprosthetic Valve Replacement

scholarly journals Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study

2021 ◽  
Vol 8 ◽  
Author(s):  
Guan-Yi Li ◽  
Yun-Yu Chen ◽  
Fa-Po Chung ◽  
Kuo-Liong Chien ◽  
Chiao-Po Hsu ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Mechanical Valve ◽  
Population Based ◽  
Bioprosthetic Valve ◽  
All Cause Mortality ◽  
Stage Renal Disease ◽  
End Stage ◽  
Esrd Patients ◽  
Bioprosthetic Valve Replacement

Background: Valve replacement is associated with worse outcomes in individuals who have end-stage renal disease (ESRD) and require a long-term renal replacement therapy. Prosthetic valve selection in patients with ESRD has remained controversial.Objective: We aimed to investigate long-term outcomes of mechanical and bioprosthetic valve replacement in individuals with ESRD.Methods: We conducted a population-based retrospective cohort study using data obtained from the Taiwan National Health Insurance Research Database. In total, 10,202 patients, including 912 ESRD and 9,290 non-ESRD patients, were selected after a 1:1 propensity-score matching based on the type of prosthetic valve used. The long-term mortality outcomes were then analyzed.Results: During a median follow-up period of 59.6 months, the Kaplan–Meier survival analysis revealed that ESRD patients who underwent mechanical valve replacement had higher rates of all-cause mortality and CV deaths than those who underwent bioprosthetic valve replacement (Log-rank test, p = 0.03 and 0.02, respectively). Multivariable regression analyses demonstrated that ESRD patients who underwent bioprosthetic valve replacement had lower rates of all-cause mortality (p < 0.001, hazard ratio: 0.88, 95% confidence interval: 0.82–0.93) and cardiovascular (CV) death (p < 0.001, hazard ratio: 0.83, 95% confidence interval: 0.76–0.90) than those who had mechanical valve replacement.Conclusion: Bioprosthetic valve replacement is significantly associated with lower rates of all-cause mortality and CV death in the ESRD population.

Bioprosthetic valve replacement in Ebstein’s anomaly

2010 ◽  
Vol 26 (3) ◽  
pp. 179-184 ◽  
Author(s):  
Shashi Prakash ◽  
Saket Agarwal ◽  
Aditya Kumar Singh ◽  
Deepak Kumar Satsangi
Keyword(s):  
Valve Replacement ◽  
Bioprosthetic Valve ◽  
Ebstein’S Anomaly ◽  
Ebstein's Anomaly ◽  
Bioprosthetic Valve Replacement

Incidence, Predictors And Outcomes Of Halt In Patients With Bioprosthetic Valve Replacement

2021 ◽  
Vol 15 (4) ◽  
pp. S56-S57
Author(s):  
K. Arunachalam ◽  
Y. Naung Htay ◽  
P. Shah ◽  
K. Nidamanuri ◽  
V. Hegde
Keyword(s):  
Valve Replacement ◽  
Bioprosthetic Valve ◽  
Bioprosthetic Valve Replacement

Swim bladder as an alternative biomaterial for bioprosthetic valves

2021 ◽  
Author(s):  
Ning Li ◽  
Xin Li ◽  
Ye Ma ◽  
Fan Qiao ◽  
Yifan Bai ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Clinical Applications ◽  
Bioprosthetic Valve ◽  
Swim Bladder ◽  
Secondary Intervention ◽  
Structural Deterioration ◽  
Cardiovascular Biomaterials ◽  
Bioprosthetic Valves ◽  
Bioprosthetic Valve Replacement

Valvular structural deterioration and calcification are the main indications for secondary intervention after bioprosthetic valve replacement, promoting an urgent requirement for more durable cardiovascular biomaterials for clinical applications.

Sign in / Sign up

Export Citation Format

Share Document